Resources with keywords: children
Patton ME, Moline HL, Whitaker M, et al.
Interim evaluation of respiratory syncytial virus hospitalization rates among infants and young children in the United States after introduction of respiratory syncytial virus prevention products (e.g., vaccines, long-acting monoclonal antibodies).
The WHO AWaRe (Access, Watch, Reserve) antibiotic book provides information on antibiotis, dose, route of administration, and duration of treatment for more than 30 of the most common clinical infections in children and adults.
Moulia DL, Wallace M, Roper LE, et al.
Updated vaccine recommendations for children > 6 months and adults >65.
Hause AM, Marquez P, Zhang B, et al.
Melgar M, Lee EH, Miller AD, et al.
Shi DS, Whitaker M, Marks KJ, et al.
Funk AL, et al.
Among 3221 SARS-CoV-2–positive youths enrolled in a global prospective cohort study with outcome data, 3.3% had severe outcomes within 14 days. Across a subgroup of 2510 SARS-CoV-2–positive youths discharged home after testing, 0.5% had severe outcomes during the 2-week follow-up period.
